Hyperbaric oxygen treatment reduces carrageenan-induced acute inflammation in rats

Eur J Pharmacol. 2001 Nov 16;431(2):265-8. doi: 10.1016/s0014-2999(01)01446-7.

Abstract

The present study was designed to assess the anti-inflammatory activity of hyperbaric oxygen treatment by comparing it with that of diclofenac, a nonsteroidal anti-inflammatory drug, and also to investigate whether hyperbaric oxygen treatment enhances the anti-inflammatory effect of diclofenac in carrageenan-induced paw edema which is commonly employed as an acute inflammation model in rats. Hyperbaric oxygen treatment and diclofenac (20 mg/kg) markedly reduced the carrageenan-induced paw edema in rats. In other words, they displayed anti-inflammatory activity. On the other hand, hyperbaric oxygen treatment did not consistently modify the anti-inflammatory effect of diclofenac in this model.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Carrageenan
  • Combined Modality Therapy
  • Diclofenac / administration & dosage
  • Diclofenac / therapeutic use
  • Disease Models, Animal
  • Edema / chemically induced
  • Edema / therapy*
  • Hindlimb
  • Hyperbaric Oxygenation*
  • Inflammation / chemically induced
  • Inflammation / therapy*
  • Male
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Diclofenac
  • Carrageenan